MYC Activity Mitigates Response to Rapamycin in Prostate Cancer through Eukaryotic Initiation Factor 4E–Binding Protein 1–Mediated Inhibition of AutophagyBala S. Balakumaran, Phillip G. Febbo(Veracyte (United States))Cancer ResearchSeptember 22, 200910.1158/0008-5472.can-09-0910Cited by 82SaveCiteExport RISWatch citationsRelated PapersGene expression correlates of clinical prostate cancer behavior|Cancer Cell|2002|2.5kmTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways|Nature Medicine|2004|956